Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsAris N. Economides, Andrew J. Murphy, Peter Matthew Lengyel, Peter H. A. Yang
Estimating the term…
Methods for modifying a genome are provided, wherein the modifications comprise null alleles, conditional alleles and null alleles comprising conditional by inversion elements. Methods are provided which afford the ability in a single targeting step to introduce an allele that can be used to generate a null allele, a conditional allele, or an allele that is a null allele and that further includes a conditional by inversion element. Introduced alleles comprise pairs of cognate recombinase recognition sites, an actuating sequence and/or a drug selection cassette, and a nucleotide sequence of interest, and a conditional by inversion element, wherein upon action of a recombinase a conditional allele with a conditional by inversion element is formed. In a further embodiment, action of a second recombinase forms an allele that contains only a conditional by inversion element in sense orientation. In a further embodiment, action by a third recombinase forms an allele that contains only the actuating sequence in sense orientation.
An in vitro method of creating a conditional allele in the genome of a mouse embryonic stem(ES) cell, comprising:
An in vitro method of creating a null allele in the genome of a mouse embryonic stem(ES) cell, comprising:
Dependencies are inferred from the claim text.